For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief data and technology officer (CDTO) ...

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted ...

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and ...

Discovery Labs owner is nearing completion of a $1 billion financing deal to "recapitalize" KOP cell and gene therapy campus ...

The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

Teva Pharmaceutical Industries Ltd. ADR 0.52% $23.98B ...

GSK has been ramping up its manufacturing for Benlysta in anticipation ... which are thought to be central to the disease process in SLE although the precise cause of the disease is unknown.

Muna will take the lead in identifying and validating new Alzheimer’s targets, while GSK will be responsible for the ...